These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 18087207)

  • 41. [Compliance problems in treatment of schizophrenic patients].
    Barnas C; Hummer M; Fleischhacker WW
    Wien Med Wochenschr; 1998; 148(11-12):281-3. PubMed ID: 9746971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Need-adapted treatment of schizophrenia: family interventions.
    Lehtinen K
    Br J Psychiatry Suppl; 1994 Apr; (23):89-96. PubMed ID: 8037906
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and resource-use outcomes of risperidone long-acting injection in recent and long-term diagnosed schizophrenia patients: results from a multinational electronic registry.
    Olivares JM; Peuskens J; Pecenak J; Resseler S; Jacobs A; Akhras KS;
    Curr Med Res Opin; 2009 Sep; 25(9):2197-206. PubMed ID: 19604073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of schizophrenia in the family].
    Boonen M; Bockhorn M
    Psychiatr Prax; 1992 May; 19(3):76-80. PubMed ID: 1635952
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Assessment of therapeutic adherence using questionnaires in patients with schizophrenia].
    István B; Agnes M
    Psychiatr Hung; 2006; 21(6):430-6. PubMed ID: 17438660
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prospective evaluation of the early course of schizophrenia in men and women after a first psychiatric hospitalization].
    Jaracz K; Górna K; Kiejda J; Rybakowski J
    Psychiatr Pol; 2008; 42(1):33-46. PubMed ID: 18567402
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Strategies for dosing and switching antipsychotics for optimal clinical management.
    Buckley PF; Correll CU
    J Clin Psychiatry; 2008; 69 Suppl 1():4-17. PubMed ID: 18484804
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improving care of patients with diabetes and CKD: a pilot study for a cluster-randomized trial.
    Cortés-Sanabria L; Cabrera-Pivaral CE; Cueto-Manzano AM; Rojas-Campos E; Barragán G; Hernández-Anaya M; Martínez-Ramírez HR
    Am J Kidney Dis; 2008 May; 51(5):777-88. PubMed ID: 18436088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The relationship between patient characteristics and psychiatric day care outcomes in schizophrenic patients.
    Miyaji S; Yamamoto K; Morita N; Tsubouchi Y; Hoshino S; Yamamoto H; Sakai Y; Tanaka K; Miyaoka H
    Psychiatry Clin Neurosci; 2008 Jun; 62(3):293-300. PubMed ID: 18588589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.
    Assion HJ; Reinbold H; Lemanski S; Basilowski M; Juckel G
    Pharmacopsychiatry; 2008 Jan; 41(1):24-8. PubMed ID: 18203048
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The management of difficult to treat patients with schizophrenia, using non-drug therapies.
    Kuipers E
    Br J Psychiatry Suppl; 1996 Dec; (31):41-51. PubMed ID: 8968654
    [No Abstract]   [Full Text] [Related]  

  • 52. Psychoeducation in schizophrenia: 7-year follow-up concerning rehospitalization and days in hospital in the Munich Psychosis Information Project Study.
    Bäuml J; Pitschel-Walz G; Volz A; Engel RR; Kessling W
    J Clin Psychiatry; 2007 Jun; 68(6):854-61. PubMed ID: 17592908
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
    Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
    Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Evaluation of the effectiveness of integrated psychological therapy in long-term evolution of patients with schizophrenia].
    Lemos Giráldez S; Vallina Fernández O; García Saiz A; Gutiérrez Pérez AM; Alonso Sánchez M; Ortega Ferrández JA
    Actas Esp Psiquiatr; 2004; 32(3):166-77. PubMed ID: 15168267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
    Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
    Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Timing of psychoeducational psychotherapeutic interventions in schizophrenic patients.
    Feldmann R; Hornung WP; Prein B; Buchkremer G; Arolt V
    Eur Arch Psychiatry Clin Neurosci; 2002 Jun; 252(3):115-9. PubMed ID: 12192468
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Insight in schizophrenia: assessment of 31 patients with different scales].
    Travers D; Levoyer D; Millet B
    Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term treatment with flupentixol results of a post-marketing surveillance study.
    Messer T; Glaser T; Landen H; Schmauss M
    J Psychopharmacol; 2009 Sep; 23(7):805-13. PubMed ID: 18562418
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Developing a global psychotherapeutic approach to schizophrenia: results of a five-year follow-up.
    Alanen YO; Räkköläinen V; Rasimus R; Laakso J; Kaljonen A
    Yale J Biol Med; 1985; 58(4):383-402. PubMed ID: 4049919
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Family therapy as a component of routine management of schizophrenic patients. A report of experiences].
    Klank I; Rost WD; Olbrich R
    Psychiatr Prax; 1998 Jan; 25(1):29-32. PubMed ID: 9530766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.